* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Saccharomyces boulardii Using Intraspecific Protoplast Fusion
Survey
Document related concepts
Transcript
Journal of Applied Sciences Research, 3(3): 209-217, 2007 © 2007, INSInet Publication Genetic Construction of Potentially Probiotic Saccharomyces boulardii Yeast Strains Using Intraspecific Protoplast Fusion 1 Nivien A. Abosereh, 1 Hassan Abdel-Latif A. Mohamed and 2Azzat B. Abd El-Chalk 1 Microbial Genetics Dept. and 2Dairy Dept., National Research Centre, Cairo, Egypt. Abstract: Highly efficient bio-therapeutic yeast Saccharomyces boulardii strains, were obtained by intraspecific protoplasts fusion. The selected fusants F1 (S.b.M1 X S.b.M 2) (ad - X lys -) and F2 (S.b.M2 X S.b.M3) (lys -´arg -) and their parents; S.b.M1(ad -), S.b.M2 (lys -) and S.b.M 3 (arg -) as well as the wild type strain (S. boulardii ) were examined by Electron microscope and tested for their anti-microbial activities, tolerance to low pH and 3% bile salt. Results showed that the number of intact cells were about 3000, 4500 and 5500 cells / ml in the protoplast suspensions of S.b.M1, S.b.M2 and S.b.M3, respectively. On the other hand, the protoplast formation percentage of S.b.M1, S.b.M2 and S.b.M3, were 1.91, 3.91 and 4.82% , respectively. The regeneration percentage of S. S.b.M1, S.b.M2 and S.b.M3, were 0.9364, 1.9273 and 2.3455%, respectively. Mixed protoplasts; (S.b.M1 X S.b.M2), (S.b.M1 X S.b.M3) and (S.b.M 2 X S.b.M3) produced hybrid fusants colonies reached to 215, 345 and 410, respectively. Results revealed that the fusion between S.b.M1 and S.b.M 2 had higher regeneration percentage (10.42%) than the other fusions (S.b.M1) X (S.b.M 3) and (S.b.M2) X (S.b.M3) which showed regeneration percentage of 8.15% and 7.94%, respectively. The produced regenerated fusants showed colonies with larger cell size than the parental strains. Electron micrographs of cell collected during generation of protoplast fusion showed that the outer membrane has peeled away from the inner membrane or no longer visible. The fusion between cells that still retain some outer membrane and thus would technically be considered spheroplasts rather than true protoplasts. Some fusants remnants of the outer membrane, thus, it is not necessary to remove the entire outer membrane in order to achieve fusion. No antimicrobial effect was scored with the tested S. boulardii strains on E. coli. The highest clear zone diameter was achieved by fusant F2 (S.b.M 2 X S.b.M3) against B. cereus, while the lowest one was achieved by S. boulardii (W .T ) against S. aurues. At low pH 3 and in the presence of 3% Bile salt, the fusant F2 (S.b.M2 X S.b.M3) gave the highest level of growth among the other tested yeast strains. This indicate that the produced intra-specific fusants of S. boulardii, have highly antagonistic effect on some pathogenic bacteria and also highly tolerate to low pH 3 and 3% Bile salts in comparison to their parents that may be due to the regulatory effect of the ploidy state. These fusants are, therefore, recommended for various medical applications. Key words: Protoplast fusion, Electron microscope, Auxotrophic mutants, Bile salts, Anti-microbial agent for the treatment of microbes associated with diarrhea and colitis[6 ]. Saccharomyces boulardii is safe, non-toxic, nonpathogenic, thermophilic yeast and its treatment alone reduced bacterial translocation. It is useful as biotherapeutic agent in combination with standard antibiotic for the treatment of and recurrent Clostridiuni difficile diarrhea and colitis. Diet supplementations with probiotics (Lactobacilli and Saccharomyces boulardii) were also helped to reduce some effects of aging [2 ,1 3 ,1 8 ]. In order to obtain strains showing more suitable properties, genetic manipulation methods have been used. Genetic improvement of Saccharomyces and other yeast strains has traditionally relied on random mutagenesis [3 8 ]. However, due to the aneuploid, diploid or polyploid nature of most strains used in beer and INTRODUCTION Several studies have been reported the use of yeasts (Saccharomyces boulardii or S. cerevisiae) as a potential bio-therapeutic agent (probiotic) for the treatment of microbes associated with diarrhea and colitis. Viable yeast cells were recently used to improve the resistance of the intestinal ecosystem to bacterial infection. The role of probiotics in preventing or curing gastrointestinal illnesses have been reported [1 9 ] and many yeast species showed potential benefits of the host, so that they could be used as bio-therapeutic agents [3 7 ]. S. boulardii is a rich source of B vitamins and chromium, so that it was used with S. cerevisiae (a commercial baker 's yeast) as a potential bio-therapeutic Corresponding Author: Nivien A. Abosereh, Microbial Genetics Dept, National Research Centre, Cairo, Egypt 209 J. Appl. Sci. Res., 3(3): 209-217, 2007 wine making, traditional crossing techniques have not been very successful. Thus, the use of new techniques such as protoplast fusion and genetic transformation is necessary. New genotypes were obtained by protoplast fusion, which showed recombinant features, while the transformed strains showed heterologous genes [2 7 ]. Protoplast fusion is versatile technique for inducing genetic recombination in a variety of prokaryotic and eukaryotic microorganisms. Protoplast is induced to fuse and form transient hybrids. During this hybrid state, the genomes may re-assort and genetic recombination can occur [2 1 ]. So far, an increasing number of recombinant strains have been formed. The aim of this research study is to obtain highly efficient Saccharomyces boulardii biotherapeutic strains through protoplast fusion techniques. harvested by centrifugation at 3000 rpm for 20 mins. The cell pellets were washed three times with distilled water and resuspended in hypertonic buffer (0.1 M Tris–HCl. pH 7.5, 2 mM EDTA, 50 mM 2Mercaptoethanol and 0.45 M KCl) and incubated at 37 o C for 10 mins with gentle agitation. The cells were again centrifuged and resuspended in lytic buffer (0.7 M KCl, 1% 2-Mercaptoethanol and 0.1% snail enzyme) and incubated at 37 o C for 17 hrs. Using microscope, the cells were periodically checked for the formation of protoplast with iodine solution (2 g potassium iodine, 1 g iodine, up to 300 ml distilled water). Protoplast was then collected by centrifugation at 3000 rpm for 10 mins, washed at least three times with the washing buffer (0.1M phosphate buffer, pH 7.5 and 0.8 M sorbitol and resuspended in the same buffer. M ATERIALS AND M ETHODS Protoplast fusion: Protoplast suspension of both parental yeast strains were mixed in 1: 1 ratio, centrifuged at 3000 rpm for 10 minutes. The pellets were resuspended in fusion buffer (10 mM Tris-HCl, pH 8.1, 10 mM CaCl2 and 35% PEG with M.W . 4000). The suspensions were incubated at 37 o C for 30 mins. 0.1 ml of the suspension was mixed with 10 ml of melted regeneration minimal medium (MMR1) and poured into plates containing a thin bottom layer of the same medium supplemented with (nutritional requirement). Plates were incubated at 37 o C for 5 days. For fusion control, parental protoplasts were submitted to the same treatment [1 2 ]. M icrobial strains and culture condition: Table (1) illustrates the microbial strains used in this investigation; three auxotroph mutants (S. b. M1, S. b. M2 and S. b. M 3) were produced after irradiation treatment to the wild type Saccharomyces boulardii by gamma radiation [1 ]. Four bacterial strains (Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus) were used as test strains in antimicrobial bioassay. M edia: Complete medium (CM ) [9 ]: The yeast strains were maintained as slant of YEP agar medium as (CM ) and stored at 5 O C. W hen required, the yeast culture was activated by transferring to YEP plates, and incubated at 37 O C for 48 hrs. Nutrient broth (NB) or Nutrient agar (NA) media [2 9 ]: The tester bacterial strains were grown at 37 0 C in NB medium or on NA medium with vigorous shaking. Minimal medium (MM) [3 3 ]: W as used to test the yeast mutants, i.e., auxotrophic cells and the induced fusants Minimal medium for regeneration (MMR) [3 1 ]: It consists of ; 0.67% yeast nitrogen base (YNB), 3% sorbitol, 0.1% glucose, 0.6% KCl and 3% agar. Regeneration minimal medium (Top layer medium) (MMR1): It is similar to MMR but without KCl and agar was reduced to 1.8%. This medium was used for the stabilization of fusion products. Electron M icroscopy (EM ): Sample of the generated fusants were centrifuged and fixed in 2% glutaraldhyde in 50 mM sodium cacoclylate buffer, pH 7.2 at 4 o C overnight. The pellets were then washed 3 times in the same buffer, post fixed in 1% osmium tetroxide in sodium cacodylate buffer for 1h at room temperature, and immersed in 1% urangl acetate for 2 hrs. The fixed samples were dehydrated with acetone and embedded in supurr's epoxy resin. Thin sections (60 ìm thick) were collected on formuar-coated EM grids and stained with uranyl acetate and lead citrate. Images were obtained on Philips CM 1 0 (FE 1 Co, Hillsboro, OR) transmission electron microscope operating at 80KV with Gatan (Pleasanton, CA) Bioscan digital camera. Induction of yeast protoplasts: Yeast cells were converted to protoplasts according to Farahank et al.[1 2 ] method with a slight modification. Yeast strains were aerobically grown to early stationary phase in 25 ml Erlenmeyer flasks containing 10 ml aliquots of CM medium for 20 hrs, at 37 o C, then the cells were Antimicrobial activity: The antimicrobial activity of the cell-free supernatants for the fusant strains against the tester organisms was determined using agar diffusion well assay[3 6 ]. Tolerance to low pH: The cells of the tested yeast 210 J. Appl. Sci. Res., 3(3): 209-217, 2007 strains were harvested from fresh culture by centrifugation (4000 rpm, 10 min. at 4 o C). The yeast cells were washed three times with sterile saline (0.85% NaCl) and inoculated at 1% in YEP broth acidified to pH (3.0) by 10% HCl according to Chou and W einer[8 ]. The aim of the present study is to use protoplast fusion technique to improve some probiotic properties (i.e. antimicrobial activity and resistant to high concentration of Bile Salt) of the S. boulardii strains. Bile Salt Tolerance: Cultures of S. boulardii were evaluated for viability and growth in YEP broth medium supplemented with 0.2% sodium thioglycolate and 3% Oxgell bile salt (Oxoid) according to El-Shafai et al.[1 1 ]. Protoplast Formation and Fusion: Biologically, species were defined as "a group of organisms that can interbreed with one another" [5 ]. However, for many microorganisms, and particularly a number of groups of yeasts and fungi, no sexual stage could be discovered RESULTS AND DISCUSSIONS Table 1: List of the m icrobial strains used M icrobial Strain Phenotype Genotype Source S. boulardii Prototrophic W ild type NRC 1 ----------------------------------------------------------------------------------------------------------------------------S.b.M 1* Auxotroph ad S.b.M 2* lys S.b.M 3* arg --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Bacillus cereus (ATC C33018)** Prototrophic M IRCEN 2 E. coli (ATC C 69337)** S. aurues (ATC C20231)** ----------------------------------------------------------------------------------------------------------------P. aeruginosa (NRRL B-272.A)** NRRL 3 * (S.b.M ) is referring to S. boulardii m utants that obtained after irradiating the wild type Saccharom yces boulardii by gam m a radiation in previous article. ** Test strains used in antim icrobial bioassay. 1 (N RC) K indly obtained from N ational Research Centre (N RC), D okki, Giza, Egypt. 2 (M IRCEN ) Kindly obtained from Egyptian M icrobial Culture Collection (EM CC) at Cairo, M icrobiological Resources C entre (M IRCEN ), Fac. of A gric., Ain Sham s U niv., Egypt. 3 (NRRL) Kindly obtained from National Centre for Agricultural Utilization Research, USA. in their life cycles, so the biological definition of a species proved unworkable. The availability of facile methods to sequence first proteins and then genes led to the rapid growth of molecular phylogenetics and the use of sequence comparisons to both define and identify species [2 3 ,2 2 ,2 6 ,3 5 ]. W hereas, S. boulardii is a wild-type strain that is rep o rted ly unable to sporulate [2 4 ,2 3 ], but its ploidy and mating type have not been published [3 9 ], so that, the protoplast fusion technique was done to obtain S. boulardii intraspecific fusants. The mutants; ( Sb.M1) and (S.b.M2) adenine and lysine auxotrophs, respectively and another mutant (S.b.M3) argenine auxotroph were used in this study (Figure 1). In figure (1) we expect that the initial colonies formed on MMR medium resulted from fused protoplasts containing genomic DNA from two parent. It appears that if fusion occurs between two auxotrophic parents , complementation between the two parental genomes can support growth on MM medium even if recombination has not occurred to combine wild type alleles into a single chromosome. During growth of the initial colonies on either M M R or M .M., the recombination can occur to generate true prototrophs. Alternatively, the parental genomes may Fig. 1: M odel for the example of heterodiploid cells obtained by fusion of protoplasts of two auxotrophic parent strains of S. boulardii. segregate during cell division without recombination, or recombination may occur in such a way that wild type alleles are not combined. In the latter cases, the resulting strains will be auxotrophs, but they will retain the enzymes that were present in the biparental progenitor. In the absence of significant protein turnover , the concentration of these enzymes will be reduced by one-half during each cell division , so that there is likely to be enough enzyme to allow synthesis of leucine, adenine or argenine for several cell 211 J. Appl. Sci. Res., 3(3): 209-217, 2007 Table 2: Protoplast form ation Parent strains N um ber of survivals cells / m l Intact yeast cells* Protoplast form ation** ------------------------------------------------------------------------------------------N um ber / m l % N um ber / m l % S.b.M 1 (ad -) 1.1´10 8 3000 0.003 2.1x10 6 1.91 -----------------------------------------------------------------------------------------------------6 S.b.M 2 ( lys ) 4500 0.004 4.3 x10 3.91 -----------------------------------------------------------------------------------------------------S.b.M 3 (arg -) 5500 0.005 5.3 x10 6 4.82 *growing on M M R m edium supplem ented with adenine or lysine or argenine. **According to the m icroscopic exam ination of the protoplast suspensions. (A) (B) (C) Fig. 2: Electron micrographs of cell collected during generation of protoplast. generation. Such heterogeneity has been well documented in previous studies of protoplast fusion [1 7 ] (D) into M MR medium supplemented with adenine or lysine or argenine to determine the number of intact yeast cells. Table (2) showed that the number of intact S.b.M1 cells was about 3000 cells / ml of protoplast suspension while it was about 4500 and 5500 cells / ml for S.b.M2 and S.b.M3, respectively. On the other hand, the protoplast formation percentage of S.b.M1 was 1.91% while it was 3.91 and 4.82% for S.b.M2 and S.b.M3, respectively. The regeneration percentage of the induced protoplasts was determined by mixing 0.1 ml of protoplast suspension with the top layer medium (M MR1) and poured onto plates containing a thin bottom layer of the regeneration medium (MMR) supplemented with 20 µg / ml of adenine or lysine or Protoplast Induction and Efficiency: An-equal number of cells (15 x 10 7 cells / ml) of S.b.M1 or S.b.M 2 or S.b.M3 were used in the protoplast induction according to Farahank et al. [1 2 ] method. After protoplast induction, protoplast formation may depend on the sensitivity of the yeast strains to lytic enzymes and on the reaction of different cells of the same culture as well as the walls of older cells being highly resistant[2 5 ]. The results indicated that the protoplasts were efficiently induced as the microscopic examination of the protoplast suspension showed that almost all the cells were converted into protoplasts within . 20 hrs. A sample of the protoplast suspensions were separated 212 J. Appl. Sci. Res., 3(3): 209-217, 2007 argenine (Table 3). The results showed that after incubation at 37 o C for 4 days, the regeneration percentage of S.b.M1 was 0.9364% while it were 1.9273 and 2.3455% for S.b.M2 and S.b.M3, respectively. The efficiency of fusion was expressed as a percentage of reverting protoplasts. Mixture of complementing protoplasts but untreated with fusion buffer were used as a control. Protoplast suspensions (4.5 ml) of both yeast strains were mixed, centrifuged and resuspended in 2 ml protoplasting buffer. Two hundreds micro-liters of the mixture were mixed with the top layer and poured onto the selective regeneration medium MMR without any supplementation of adenine or lysine or argenine. Table (4) showed that after 7 days of incubation at 37 o C, 215, 345 and 410 hybrid fusants colonies were found per mixed protoplasts, (S.b.M1 X S.b.M2), (S.b.M1 X S.b.M 3) and (S.b.M 2 X S.b.M 3), respectively. The fusion between (S.b.M1) X (S.b.M2) had higher regeneration percentage (10.42%) when grown on M MR medium than the other fusions (S.b.M1) X (S.b.M3) and (S.b.M2) X (S.b.M3) that showed regeneration percentage of 8.15 and 7.94%, respectively. These results are in agreement with the results of Stobinska et al.[3 2 ]. The use of PEG as a spheroplast fusionic agent has a number of limitations, which have been discussed in detail by [4 1 ]. Data presented in this study showed that regeneration of protoplasts produced large sized cell colonies than the parental strains (Figure 2). T his may due to the effect of hybrid vigour. These results are in agreement with the results of Dzuiba and Chmeilewska [1 0 ]. Results of intergeneric protoplast fusion between Saccharomyces cerevisiae and Kluveromyces lactis induced by PEG were reported by Borun and Jinke [4 ]. They stated that the cell volume of fusant was about the sum of the cells of two parents. DNA contents of most fusant were about two to three time higher than that of the parents. On the other hand, Selebane et al.[3 0 ] found that fusants of Candida shehatae and Pichia stipitis showed only marginal in cell DNA content when compared with their parents. Figures (2-A and 2-B) showed electron micrographs of cell collected during generation of the fused protoplasts. For most of the cells in the field, the outer membrane has peeled away from the inner membrane or no longer visible. W e have observed fusion between cells that still retain some outer membrane and thus would technically be considered spheroplasts rather than true protoplasts [4 0 ]. W hile as, Figures (2-C and 2-D) show the cells which contain the nucleuses of the parents cells after complete fusion occurred. Based upon the results reported here, we suggest that the efficiency of protoplast fusion is critically dependent upon both technical and organismic factors. W e note that some fusants remnants of the outer membrane, thus, it is not necessary to remove the entire outer membrane in order to achieve fusion. Two of the produced fusants were isolated, named F1 (resulted after fusion between S.b.M1 and S.b.M2) and F2 (resulted after fusion between S.b.M2 and S.b.M3) and subjected to further studies. Antimicrobial Activity: The ability of cell-free of five yeast strains; S. boulardii (W .T.) strain and three mutants; (S.b.M 1), (S.b.M2) and (S.b.M3) the adenine, lysine and argenine auxotrophs, respectively as well as two fusants; F1 (S.b.M1 X S.b.M2) (ad -´lys -) and F2 (S.b.M2 X S.b.M3) (lys -´arg -) to retard or suppress the gro w th o f so m e ha rm ful ind ica to r b a c teria (Staphylococcus aureus, Bacillus cereus, Pseudomonas aeruginosa and Escherichia coli) is illustrated in Table (5) and Figure (3). Table (5) revealed that in case of E. coli, negative results of the antimicrobial effects of the tested yeast strains were found. It also showed that S. boulardii wild type strain was not able to give any antimicrobial effect on E. coli and P. aeruginosa as reported by Kuhle et al. [2 0 ]. The diameter of clear zone was achieved by fusant F2 (S.b.M2 X S.b.M3) against B. cereus (11 mm) was larger than their parents; S.b.M2 and S.b.M3 and the wild type strain (S. boulardii) that showed (0.0, 0.0 and 8 mm, respectively). W hile the smallest clear zone diameter was achieved by fusant F1 (S.b.M1 X S.b.M2) and their parent S.b.M1 against P. aeruginosa (8 mm).as well as the wild type strain (S. boulardii) and the other parent S.b.M2 that showed (0.0 and 10 mm, respectively). Figure (3) shows the clear zone apparent when the two fusants; F1 (S.b.M1 X S.b.M2) and F2 (S.b.M2 X S.b.M3) were used as antagonistic effecter on Pseudomonas aeruginosa comparison with the wild type strain (S. boulardii). Tolerance of Low pH: The ability to grow (tolerance) at pH 3 was varied among the two fusant strains and their parents as well as the original strain S. boulardii (W .T) (Table 6). Data showed clearly that the logarithmic scale of colony-forming units(log CFU) of survival percentage at pH 3. Results indicated that fusant F2 (S.b.M2 X S.b.M3) gave the highest level of growth being (5.0 log CFU ) and the other fusant F1 (S.b.M1 X S.b.M2) showed (3.8 log CFU). W hile as their parents, (S.b.M1), (S.b.M2) and (S.b.M3) as well as the wild type strain (S. boulardii ) that showed level of growth being (3.9, 4.5, 3.2 and 4.7 log CFU, respectively). 213 J. Appl. Sci. Res., 3(3): 209-217, 2007 Table 3: Regenerated colonies on M M R Parent strains N um ber of survivals colonies / m l* S.b.M 1 (ad -) 1.1´10 8 S.b.M 2 ( lys -) Num ber of regenerated colonies / m l** % Regeneration 5.12´10 6 0.9364 ------------------------------------------------------------------------6.83´10 6 1.9273 ------------------------------------------------------------------------6.08´10 6 2.3455 S.b.M 3 (arg -) *Grow ing on CM . **Growing on M M R m edium supplem ented with adenine ,lysine, or argenine. Table 4: Form ation of hybrid fusants colonies. Y east hybrids N um ber of Protoplast form ation / m l* N um ber of hybrid fusants colonies / m l** % Protoplast fusion S.b.M 1 X S.b.M 2 2063 215 10.42 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 1 X S.b.M 3 4233 345 8.15 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 2 X S.b.M 3 5163 410 7.94 *According to the m icroscopic exam ination of the protoplast suspensions. **Appeared on M M R m edium without any supplem entation. Table 5: The antim icrobial effect of cell-free Saccharom yces boulardii fusants and their parents on various indicator bacteria. Y east strains D iam eter of inhibition zone (m m ) of indicator bacteria ------------------------------------------------------------------------------------------------------------------------------------------B. cereus E. coli P. aeruginosa S. aureus S. boulardii (W .T.) 8 0.0 0.0 5 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 1 (ad -) 0.0 0.0 8 8 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 2 (lys ) 0.0 0.0 10 0.0 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 3 (arg -) 0.0 0.0 8 6 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------F1 (S.b.M 1XS.b.M 2)* 0.0 0.0 8 10 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------F2 (S.b.M 2XS.b.M 3)* 11 0.0 9 0.0 * Fusants Table 6: Survival (as Percentage of log CFU ) of Saccharom yces boulardii fusants and their parents at the low pH 3. S. boulardii strain Control pH 3 --------------------------------------------------------------------------------------------------------------------Percentage of logarithm ic colony-form ing units(% Log CFU ) S. boulardii (W . T.) 7.2 4.7 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 1 (ad -) 7.6 3.9 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 2 (lys -) 7.9 4.5 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 3 (arg -) 7.1 3.2 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------F1 (S.b.M 1XS.b.M 2) * 7.8 3.8 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------F2 (S.b.M 2XS.b.M 3) * 7.9 5.0 *Fusants Table 7: Survival (as Percentage of log CFU ) of Saccharom yces boulardii fusants and their parents in the presence of 3% bile salt. S. boulardii strain Control 3 % bile salt -------------------------------------------------------------------------------------------------------------------Percentage of logarithm ic colony-form ing units(% log CFU )) S. boulardii (W T) 8.0 7.7 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 1 (ad ) 7.6 6.5 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 2 (lys -) 7.2 7.3 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S.b.M 3 (arg -) 7.9 6.5 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------F1 (S.b.M 1XS.b.M 2)* 8.1 6.1 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------F2 (S.b.M 2XS.b.M 3) * 8.5 8.3 * Fusants 214 J. Appl. Sci. Res., 3(3): 209-217, 2007 Fig. 3: Pseudomonas aeruginosa inhibition by S. boulardii fusants. Bile Salt Tolerance: The ability to grow (tolerance) in the presence of 3% Bile salt was varied among the two fusant strains and their parents as well as the original strain S. boulardii (W .T) (Table 7). Data showed clearly that the logarithmic scale of colony-forming units( log CFU ) of survival percentage in the presence of 3% Bile salt. Results indicated that fusant F2 (S.b.M2 X S.b.M3) gave the highest level of growth being (8.3 log CFU) and the other fusant F1 (S.b.M 1 X S.b.M2) showed (6.1 log CFU). W hile as their parents, (S.b.M 1), (S.b.M2) and (S.b.M3) as well as the wild type strain (S. boulardii ) showed level of growth being (6.5, 7.3, 6.5 and 7.7 log CFU, respectively). Although the Bile salt concentration of the human G1 tract varies, the mean intestinal Bile concentration is believed to be 0.3% , [1 5 ]. This concentration of Bile has consequently been used in most studies screening for Bile resistant strains [1 6 ,7 ]. This property may provide these strains with an advantage in vivo. These results are generally in harmony with those reported by Kuhle et al. [2 0 ] who indicated that Saccharomyces boulardii displayed good resistance to 0.3% Bile salt . The efficiency of genome shuffling is a function of the efficiencies of generation and fusion of protoplasts, recovery of protoplasts after fusion, recombination between heterogeneous chromosomes in the diploid or multiploid cells obtained after fusion, and the eventual segregation of true proto-fusants containing only one genome [2 8 ]. Genetic improvement of Saccharomyces and other yeast strains has traditionally relied on random mutagenesis or classical breeding and genetic crossing (i.e. protoplast fusion) of two strains followed by screening for mutant or fusants exhibiting enhanced properties of interest[3 8 ,3 4 ]. The Appearance of characters in the fusants progeny that does not exist in their parents may be due to the regulatory effects of the ploidy state. Galitski et al. [1 4 ] reported that microarray-based gene expression analysis identified genes showing ploidy-dependent expression in isogenic Saccharomyces cerevisiae strains that varied in ploidy from haploid to tetraploid. These genes were induced or repressed in proportion to the number of chromosome sets, regardless of the mating type. Ploidy-dependent repression of some G 1 cyclins could explain the enlarged cell size associated with higher ploidies, and suggests ploidy-dependent modifications of cell cycle progression. Moreover, ploidy regulation of the FLO11 gene had direct consequences for yeast development. Also, Andalis et al.[3 ] noted that they cannot eliminate the possibility that one or more of the genes whose regulation differs in tetraploids is responsible for their failure to survive in stationary phase. From the present results, it is concluded that the produced intraspecific fusants of S. boulardii,-that have a highly antagonistic effect on some pathogenic bacteria and also have a highly tolerate to low pH degree and high bile salts concentration than their parents may be due to the regulatory effect of the ploidy state - are recommended for various medical applications. REFERENCES 1. 215 Abd El-Khalek, A.B., N.A. Abosereh and E.A.M. Soliman, 2006. Genetic improvement of some probiotic yeast important properties. Research J. of Agric. Biology Science, 2: 478-482. J. Appl. Sci. Res., 3(3): 209-217, 2007 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. Akyol, S., M .R. M as, B. Comert, U. Ateskan, M . Yasar, H. Aydogen, S. Deveci, C. Akay, N. Mas, N. Yener and I.H. Kocar, 2003. The effect of antibiotic and probiotic infections and oxidative stress paramental acute necrotizing pancreatitis, pancreas, 26: 363-367. Andalis, A.A., Z. Storchova, C. Styles, T. Galitski, D. Pellman and G.R. Fink, 2004. Defects arising from whole-genome duplications in Saccharomyces cerevisiae. Genetics 167: 1109–1121. Borun, Z. and C. Jinke, 1990. Construction of lactose fermenting and ethanol producing fusants by intergeneric protoplasts fusion in yeast. Acta. Microbiol. Sin., 30: 182-188. Brown, T.A., 2002. Genomes. BIOS Scientific Publishers, New York. Camacho-Ruiz, L., N. Perez-Guerra and R. Perez, 2 0 0 3 . F actors affecting the grow th of Saccharomyces cerevisiae in batch culture and in solid sate fermentation. EJEAFChe, 2: 531-542 Chateau, N., A.M . Descchamps and A.H. Sassi, 1994. Heterogeneity of Bile salts resistance in the Lactobacillus isolates of a probiotic consortium. Letters App. Microbiol., 18: 42-44. Chou, L.S. and B . W einer, 1999. Isolation and characterization of acid and bile tolerant isolates from strains of lactobacillus acidophilus. J. Dairy Sci., 82: 23-31. Cox, B.S. and E.A. Bevan, E.A., 1962. Aneuploidy in yeasts. New Phytol., 61:342-355. Dzuiba, E . and J. Chmeilewska, 2002. Fermentative activity of somatic hybrids of Saccharomyces cerevisiae and Candida shehatae or Pachysolen tannophilus. EJPU, 5: 1-15. El-Shafai, K., G.A. Ibrahim and N.F. Tawfik, 2002. Beneficial uses of locally isolated lactic acid bacteria. Egyptian J. Dairy Sci., 30: 15-25. Farahank, F.T.S., D.D.Y. Ryu and D. Ogrydziak, 1986. Construction of lactose-assimilating and high ethanol producing yeasts by protoplast fusion. Appl. Environ. Microbiol., 51: 362-367. Gaeon, D., H. Garcia, L. W inter, N. Rodriguez, R. Quintas, S.N. Gonzalez and G. Oliver, 2003. Effect of Lactobacillus strains and Saccharomyces boulardii on persistant diarrhea in children. Medicina Bueons Aires. 63: 293-298. Galitski, T., A.J. Saldanha, C.A. Styles, E.S. Lander and G.R. Fink, 1999. Ploidy regulation of gene expression. Science. 285: 251-254. Gilliland, S.E., C.R. Nelson and C. Maxwell, 1985. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbial, 49: 377-381. 16. Golden, B., S. Gorbach, M. Saxelin, S. B arakat, L. Gualtieri and S. Salminen, 1992. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Digestive Diseases and Sciences, 37: 121-128. 17. Grandjean, V., Y. Hauck, J. LeDerout and L. Hirshbein, 1996. Noncomplementing diploids from Bacillus subtilis protoplast fusion, relationship between maintenance of chromosome inactivation and segregation capacity. Genetics, 144: 871-881. 18. Hebuterne, X., 2003. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care. 6: 49-54. 19. Kopp–Hoolihan, L., 2001. Prophylactic and therapeutic uses of probiotics: A review. J. Am. Diet Assoc., 101: 299-341. 20. Kuhle, A., A. Skovgaardij and L. Jaspersen, 2005. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food borne Sachharomyces cerevisiae straits. Intl. J. Food Microbiol., 101: 29-39. 21. Martins, C.V.B., J. Horii and A.P. Kleiner, 2004. C hara cte riz atio n of fusion produc ts from protoplasts of yeasts and their segregates by electrophortic karyotyping and RAPD. Rev. Microbial., 30: 1- 4. 22. Mathews, C.K., K.E. van Holde and K.G. Ahern, 2000. Biochemistry. Benjamin/Cummings, San Francisco, CA. 23. McCullough, M.J., K.V. Clemons, J.H. M cCusker and D.A. Stevens, 1998. Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). J. Clin. Microbiol., 36: 2613–2617. 24. McFarland, L. V. (1996). Saccharomyces boulardii is not Saccharomyces cerevisiae. Clin. Infect. Dis. 22: 200–201. 25. Muralidhar, R.V. and T. Panda, 2000. Fungal pro to plast fusion – a revisit. B ioprocess Engineering, 22: 429-431. 26. Porwollik, S., R.M. W ong and M. McClelland, 2002. Evolutionary genomics of Salmonella: Gene acquisitions revealed by microarray analysis. Proc. Natl. Acad. Sci,. 99: 8956–8961. 27. Rose, A.H. and J.S. Harrison, 1993. Introduction. In: Rose, A. H.; Harrison, J. S. (eds) The yeasts: Yeast Technology Academic Press, London, 1993. U. 5, pp. 1-6. 28. Sambrook, J. and D.W . Russell, 2001. Molecular cloning. A laboratory M anual, third ed. Gold Spring Harbor Laboratory Press, Gold Spring Harbor. J.Y. 29. Sarkar, A., K .A. Kumar, N.K. Dutta, P. Chakraborty and S.G. Dastidar, 2003. Evaluation of in vitro and in vivo antibacterial activity of dobutamine hydrochloride. Indian Journal of Medical Microbiology, 21: 172-178 216 J. Appl. Sci. Res., 3(3): 209-217, 2007 30. Selebane, E., R. Govindan, D. Pillay, B . Pillay and A.S. Gupthar, 1993. Genomic comparisons among parental and fusant strains of Candida shehatae and Pichia stipitis. Current Genetics, 23: 468-471. 31. Sipiczi, M. and L. Fereczy, 1977. Protoplast fusion of Schizosaccharom yces pombe auxotrophic mutants of identical mating type. Mol. Gen. genet., 151: 77-81. 32. Stobinska, H., D. Kregiel and H. Oberman, 1991. Improvement of Schwanniomyces accidental is yeast strains by mutation and regeneration of protoplasts, Acta Alim, Polon, XVII / XLI, (2): 145-158. 33. Suzuki, T., Y. Sumino, S. Akiyama and H. Fukuda, 1970. Biosynthesis of citric acid. Ger. Offen., 2 :517. Chem. Abstr., 76(9): 44687C (1972). 34. Tahoun, M.K., T.M. El-Nemr and O.H. Shata, 2002. A recombinant Saccharomyces cerevisiae strain for efficient conversion of lactose in salted and unsalted cheese whey into ethanol. Nahrug, 46: 321-326. 35. Thao, M.L., L. Baumann, J.M. Hess, B.W . Falk, J.C. Ng, P.J. Gullan and P. Baumann, 2003. Phylogenetic evidence for two new insectassociated Chlamydia of the family Simkaniaceae. Curr. Microbiol., 47: 46–50. 36. Varadaraj, M.C., N. Devi, N. Keshava and S.P. M anjrekar, 1993. Antimicrobial activity of neutralized extracellular culture filtrates of lactic acid bacteria isolated from a cultured Indian. Milk Product ('dahi'). Intern. J. Food. Microbiol., 20: 259-267. 37. Varga, E. and A. Maraz, 2002. Yeast cells as source of essential microelements and vitamins B 1 and B 2 . Acta Alimentaria, 31: 393-505. 38. W ang, B.D., D.C. Chen and T .T. Kuo, 2001. Characterization of Saccharomyces cerevisiae mutant with over secretion phenotype. Appl. Microbial. Biotechnol., 55: 712-720. 39. W armington, J.R., R.P. Green, C.S. Newlon and S.G. Oliver, 1987. Polymorphisms on the right arm of yeast chromosome III associated with Ty transposition and recombination events. Nucleic Acids Res., 15: 8963–8982. 40. W ei, W ., K. W u, Z. Xie and X. Zhu, 2001. Intergeneric protoplast fusion between Kluveromyces and Saccharomyces cerevisiae to produce sorbitol from Jerusalem artichokes. Biotechnology. Lett., 23: 799-803. 41. Zimmermann, U. and J. Viehken, 1982. Electric field induced cell-to-cell fusion. J. of Membrane Biology, 67: 165-182. 217